![Li Zeng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Li Zeng
Directeur/Membre du Conseil chez
EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED
Profil
Li Zeng currently works at Extrawell Pharmaceutical Holdings Ltd., as Independent Non-Executive Director from 2024 and CytoCares Shanghai, Inc., as Chief Operating Officer.
Dr. Zeng received his undergraduate degree in 2000 from Fudan University and doctorate degree in 2005 from Fudan University.
Postes actifs de Li Zeng
| Sociétés | Poste | Début |
|---|---|---|
| EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED | Directeur/Membre du Conseil | 07/06/2024 |
CytoCares Shanghai, Inc.
 CytoCares Shanghai, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative multispecific antibody drugs for oncology and autoimmune diseases | Directeur des opérations | - |
Formation de Li Zeng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Extrawell Pharmaceutical Holdings Ltd.
 Extrawell Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoCares Shanghai, Inc.
CytoCares Shanghai, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative multispecific antibody drugs for oncology and autoimmune diseases | Health Technology |
